Both HIF1α and HIF2α regulate GBM growth initially, but with tumour development, the regulation of HIF2α decreases, while HIF1α becomes increasingly important; eventually, GBM development is regulated by only HIF1α1,2, suggesting that targeting HIF1α alone can inhibit GBM growth. The gene discussed is EPAS1; the disease is glioblastoma.